Back

The new generation of small interfering RNAs directed against apoprotein(a): focus on the safety and efficacy of zerlasiran and lepodisiran

Cardiovascular Research

29 September 2025
Organised by: Logo
Read full article
ESC Journals

Contributors

Andrea Baragetti
Andrea Baragetti

Author

Giuseppe Danilo Norata
Giuseppe Danilo Norata

Author

University of Milan Milan , Italy

You may be interested in
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Dose-response and efficacy ceiling of zilebesiran: a bayesian non-linear spline meta-analysis of phase 1 and KARDIA phase 2 trials
29 August 2026
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources